Early stage results from a phase 1/2 clinical trial of the University of Oxford’s vaccine candidate against SARS-CoV-2 have just been published in The Lancet.
The scientists leading the trial were available to describe their results and to answer questions from journalists at this online press briefing.
Prof Andrew Pollard, chief investigator on the study, and Professor of Paediatric Infection and Immunity, University of Oxford
Prof Sarah Gilbert, lead researcher of the vaccine development programme, and Professor of Vaccinology, University of Oxford
Prof Adrian Hill, Director of the Jenner Institute, University of Oxford
Dr Teresa Lambe, Associate Professor & Jenner Investigator, the Jenner Institute, University of Oxford
Dr Sandy Douglas, Research Group Leader, the Jenner Institute, University of Oxford